In most tumor cell lines, including Tsc1 null and Tsc2 null MEF cell lines, treatment with rapamycin or RAD001 leads to phosphorylation of AKT at the S473 site, and increased activation [11,12,20]. This evidence concerns the gene TSC1 and neoplasm.